PPMS- Disease Overview, Epidemiology and Drug Overview
Report gives the overview of Primary progressive multiple sclerosis disease indication in detail, highlights the PPMS epidemiology in the present scenario and in future (forecasted) as well in the key geographies across the globe and elaborates on the drugs prescribed and expected to be prescribed in PPMS by the physicians.
Multiple Sclerosis Definition
Types of MS
SPMS definition
Causes of PPMS
Profile of PPMS patient
Symptoms of PPMS patient
Disease progression and impact on QoL
Disease diagnosis
Disease Epidemiology in key markets
Factors influencing Physician prescription decision
DMTs for PPMS
Types of MS
SPMS definition
Causes of PPMS
Profile of PPMS patient
Symptoms of PPMS patient
Disease progression and impact on QoL
Disease diagnosis
Disease Epidemiology in key markets
Factors influencing Physician prescription decision
DMTs for PPMS
More Publications
Alzheimer's: Pipeline Assessment and Insights
US$ 2,000.00
March 2018
100 pages
Epilepsy: Epidemiology Overview and Insights
US$ 2,000.00
March 2018
50 pages
Attention Deficit Hyperactivity Disorder (ADHD): Market Intelligence Review and Insights
US$ 2,500.00
March 2018
50 pages
COPD: Disease Inights and Market Forecasts to 2024
US$ 5,000.00
March 2018
120 pages
Depression: Epidemiology Overview and Insights
US$ 2,000.00
March 2018
50 pages
